Aduro Biotech IPO priced at $17 per share

April 14, 2015 9:46 PM

68 0

April 14 (Reuters) - Aduro Biotech Inc's initial public offering has been priced at $17 per share, an underwriter said, valuing the cancer immunotherapy drug developer at about $1 billion.

The upsized offering, which was priced on par with the company's expectation, raised about $119 million.

Also read: CrowdStrike raises $200 million, continues to evaluate IPO: CEO

Read more

To category page